June 17, 2024 – Page 5 – Goldea Capital

Allied Announces June 2024 Distribution

Written by Customer Service on June 17, 2024. Posted in Dividend Reports And Estimates.

TORONTO, June 17, 2024 (GLOBE NEWSWIRE) — Allied Properties REIT (“Allied”) (TSX:AP.UN) announced today that the Trustees of Allied have declared a distribution of $0.15 per unit for the month of June 2024, representing $1.80 per unit on an annualized basis. The distribution will be payable on July 15, 2024, to unitholders of record as at June 28, 2024. About Allied Allied is a leading owner-operator of distinctive urban workspace in Canada’s major cities. Allied’s mission is to provide knowledge-based organizations with workspace that is sustainable and conducive to human wellness, creativity, connectivity and diversity. Allied’s vision is to make a continuous contribution to cities and culture that elevates and inspires the humanity in all people. FOR FURTHER INFORMATION, PLEASE CONTACT: Cecilia C. Williams, President and Chief...

Energy Systems Group Expands National Reach with Acquisition of Yearout Energy Services

Written by Customer Service on June 17, 2024. Posted in Mergers And Acquisitions.

NEWBURG, Ind., June 17, 2024 (GLOBE NEWSWIRE) — Energy Systems Group (ESG), a leading provider of sustainable infrastructure and energy services, announced today the acquisition of Yearout Energy Services. Through this acquisition, Energy Systems Group continues its strategic expansion into target markets, enhances its service offering, and diversifies its customer base in key Southwest states, including Texas, Colorado, Arizona, and New Mexico. Earlier this year, Energy Systems Group also announced the merger with PacificWest Energy Solutions, a California-based firm. Together with Yearout, these moves solidify Energy Systems Group’s national presence and expand its capabilities to reach new end markets. The combined group will deliver comprehensive solutions to public and private sector building infrastructure owners, including...

Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate

Written by Customer Service on June 17, 2024. Posted in Public Companies.

First regulatory submission completed for CHIKV VLP seeking approval of the vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older Represents first BLA for a chikungunya vaccine for adolescents COPENHAGEN, Denmark, June 17, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced the completion of the rolling submission process which was initiated in April 2024 with the U.S. Food and Drug Administration (FDA) for a Biologics License Application (BLA) for the licensure of its CHIKV VLP vaccine candidate for immunization against chikungunya virus infection in individuals 12 years of age and older. Pending acceptance from the FDA, the BLA could support a potential approval of the vaccine in the first half of 2025. The BLA submission includes results from two phase 3 clinical trials...

WTW announces appointment of Len Graziano as Casualty Strategy and Execution Leader for CRB NA

Written by Customer Service on June 17, 2024. Posted in Public Companies.

NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking, and solutions company, today announced the appointment of Len Graziano as Casualty Strategy and Execution Leader within Corporate Risk and Broking, North America (CRB NA). In his new role, Graziano will further promote the strategic alignment of all casualty product lines by incorporating industry vertical specialization, talent mapping, and go-to-market strategy differentiation. Graziano joins WTW from Aon, where he led the Excess Casualty practice, where he managed a team of nearly 50 brokers focused on casualty risk solutions for clients. His team was dedicated to delivering complex umbrella and excess liability placements across global markets. Graziano brings strong experience with understanding the unique casualty exposures across...

Form 8.3 – [LOK’N STORE GROUP PLC – 14 06 2024] – (CGWL)

Written by Customer Service on June 17, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree LOK’N STORE GROUP PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date position...

Form 8.3 – [KEYWORDS STUDIOS PLC – 14 06 2024] – (CGWL)

Written by Customer Service on June 17, 2024. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients) (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree KEYWORDS STUDIOS PLC (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A (e) Date position...

Digerati Technologies Reports Revenue of $7.430 Million for Third Quarter Fiscal Year 2024

Written by Customer Service on June 17, 2024. Posted in Earnings Releases And Operating Results.

– Non-GAAP Adjusted EBITDA – OPCO(1) of $0.784 Million – SAN ANTONIO, June 17, 2024 (GLOBE NEWSWIRE) — Digerati Technologies, Inc. (OTCQB: DTGI) (“Digerati” or the “Company”), a provider of cloud services specializing in UCaaS (Unified Communications as a Service) solutions for the small to medium-sized business (“SMB”) market, announced today financial results for the three and nine months ended April 30, 2024, the Company’s third quarter for its Fiscal Year 2024. Key Financial Highlights for the Three Months Ended April 30, 2024 (Compared to Three Months Ended April 30, 2023) Revenue decreased 5% to $7.430 million compared to $7.837 million. Gross profit decreased 9% to $4.518 million compared to $4.958 million. Gross margin decreased to 60.8% compared to 63.3%. Non-GAAP EBITDA from income, as adjusted...

Philips Zenition 90 Motorized receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm

Written by Customer Service on June 17, 2024. Posted in Public Companies.

Physicians using the Zenition 90 Motorized mobile X-ray system Physicians using the Zenition 90 Motorized mobile X-ray system during an intervention System image of Philips Zenition mobile X-ray solution June 17, 2024 Intuitive motorization for greater control and high-power (25 kW [1]) for state-of-the-art image quality supports complex vascular needs and a full range of clinical procedures Automated workflows contribute to greater flexibility and independence for clinicians, providing more time to focus on achieving the best possible outcomes for patients Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, designed to help clinicians deliver high-quality...

iTeos and GSK Initiate GALAXIES Lung-301 Phase 3 Study, Assessing Belrestotug and Dostarlimab in Previously Untreated, Unresectable Locally Advanced / Metastatic PD-L1 Selected Non-Small Cell Lung Cancer

Written by Customer Service on June 17, 2024. Posted in Public Companies.

WATERTOWN, Mass. and GOSSELIES, Belgium, June 17, 2024 (GLOBE NEWSWIRE) — iTeos Therapeutics, Inc. (Nasdaq: ITOS) (“iTeos”), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, and its development partner GSK, have initiated the first, global Phase 3 registration study of belrestotug + dostarlimab doublet versus placebo + pembrolizumab in patients with previously untreated, unresectable, locally advanced or metastatic PD-L1 selected non-small cell lung cancer (NSCLC). “With the initiation of the first Phase 3 study for belrestotug, we are entering a monumental stage in our journey to develop a world-leading oncology company. Nearly 70% of patients with first-line PD-L1 high non-small cell lung cancer rely upon a chemotherapy-free regimen....

Identity and Access Management Software Provider BIO-key Reports Q1’24 Revenue of $2.2M and Positive Operating Cash Flow; Hosts Investor Call Tuesday, 10am ET

Written by Customer Service on June 17, 2024. Posted in Earnings Releases And Operating Results.

HOLMDEL, N.J., June 17, 2024 (GLOBE NEWSWIRE) — BIO-key® International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer Identity and Access Management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication, announced results for its first quarter ended March 31, 2024 (Q1’24). Note, BIO-key’s results for the first three quarters of 2023 were restated at year-end and filed with the Company’s 2023 Form 10-K, and as a result Q1’23 comparisons in this release have been restated. BIO-key will host an investor call Tuesday, June 18th at 10:00am ET (details below). Q1 Financial Highlights Q1’24 revenues of $2.2M were in line with Q1’23 and increased 19.5% from Q4’23 revenues of $1.8M Gross profit increased to $1.9M (86.3% gross margin) from $0.9M (40% gross...

Day: June 17, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice